DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO R...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LAUSANNE, Switzerland, January 12, 2023, /PRNewswire-AsiaNet/-- - Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment.- Debi...
Authors: LATEST ASIANET NEWS RELEASES